Niagen Bioscience Inc

NAGE | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.04

+$0.05 (+1.67%)

At close: Sep 21, 2026, 4:00 PM ET

$3.09

+$0.05 (+1.63%)

Pre-market: Sep 22, 2026, 7:04 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	129.42M	99.6M	83.57M	72.05M	67.45M	59.26M
Cost of Revenue	46.23M	38.01M	32.79M	29.25M	25.96M	23.98M
Gross Profit	83.19M	61.59M	50.78M	42.8M	41.49M	35.27M
Operating Income	14.3M	7.73M	-5.6M	-18.63M	-27.07M	-19.85M
Interest Income	2.13M	1.13M	661K	3K	n/a	n/a
Pretax Income	18.19M	8.86M	-4.94M	-16.54M	-27.13M	-19.93M
Net Income	17.38M	8.55M	-4.94M	-16.54M	-27.13M	-19.93M
Selling & General & Admin	62.56M	47.84M	51.42M	56.6M	64.73M	51.71M
Research & Development	6.33M	6.02M	4.96M	4.83M	3.83M	3.42M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	68.89M	53.86M	56.38M	61.43M	68.56M	55.13M
Interest Expense	n/a	n/a	n/a	n/a	55K	71K
Selling & Marketing Expenses	35.51M	29.47M	26.44M	28.31M	28.35M	20.95M
Cost & Expenses	115.13M	91.87M	89.17M	90.68M	94.52M	79.11M
Income Tax Expense	810K	305K	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	79.18M	85.42M	70.54M	68.92M	67.19M	61.07M
Shares Outstanding (Diluted)	85.44M	79.72M	74.99M	69.73M	67.19M	61.07M
EPS (Basic)	0.22	0.10	-0.07	-0.24	-0.40	-0.33
EPS (Diluted)	0.20	0.11	-0.07	-0.24	-0.40	-0.33
EBITDA	19.64M	10.34M	-3.23M	-14.66M	-25.45M	-18.34M
EBIT	18.19M	8.86M	-4.94M	-16.54M	-27.07M	-19.85M
Depreciation & Amortization	1.45M	1.48M	1.71M	1.88M	1.63M	1.51M